United-Guardian — Q3 2026 Earnings Summary

Financial Performance:

• Third quarter net sales increased 54% year-over-year to $3,494,780 from $2,264,261 in 2025.
• Third quarter net income surged 247% to $930,912 ($0.20 per share) from $268,441 ($0.06 per share) in 2025.
• Nine-month net sales increased 25% year-over-year to $9,475,269 from $7,583,613 in 2025.
• Nine-month net income increased 70% to $2,478,393 ($0.54 per share) from $1,456,162 ($0.32 per share) in 2025.
• Third quarter income from operations rose to $1,108,928 from $215,072 in 2025.
• Nine-month income from operations rose to $2,505,502 from $1,521,447 in 2025.
• Third quarter total costs and expenses were $2,385,852 compared to $2,049,189 in 2025.
• Nine-month total costs and expenses were $6,969,767 compared to $6,062,166 in 2025.
• Third quarter provision for income taxes was $242,656 compared to $58,034 in 2025.
• Nine-month provision for income taxes was $645,918 compared to $368,874 in 2025.
• Weighted average shares remained constant at 4,594,319 for both periods.
• Nine-month settlement income contributed $339,493, with no comparable amount in 2025.
• Nine-month gain on sale of asset was $8,310, with no comparable amount in 2025.

Guidance and Future Outlook:

• Management plans to continue building on current growth initiatives.
• Pharmaceutical segment is evaluating marketing efforts to increase awareness of Renacidin among healthcare professionals.
• Personal care segment has a new product in late-stage development scheduled for launch early next year.
• Company expresses hope that continued efforts will drive further growth and increased sales.

Business Segments and Product Lines:

• Pharmaceutical sales grew 29% year-over-year, driven primarily by Renacidin.
• Pharmaceutical growth was partly attributable to expanded formulary coverage achieved earlier in the year.
• Cosmetic ingredient sales surged 187% year-over-year, led by increased purchases from Ashland Specialty Ingredients ("ASI").
• Medical lubricants grew 20% year-over-year, reflecting increased purchases from a customer in India.
• Personal care and medical lubricants both posted sales increases in the third quarter.

Management Commentary and Tone:

• President Donna Vigilante described the third quarter as "exceptionally strong."
• Management stated they are "very excited" regarding the third quarter results.
• Management expressed being "very pleased" with performance for the first nine months of 2026.
• Management noted that growth initiatives have produced "encouraging results."

Other Key Points:

• United-Guardian is a diversified life sciences and personal care ingredients company developing, manufacturing, and commercializing proprietary pharmaceuticals, medical lubricants, specialty cosmetic ingredients, and consumer wellness products.
• The press release includes forward-looking statements subject to risks and uncertainties detailed in SEC filings.
• Contact information provided for Donna Vigilante is (631) 273-0900 and dvigilante@u-g.com.